Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Deliyingjie Pharmaceutical Technology is a specialized Contract Research Organization (CRO) headquartered in the Daxing Bio-medicine Industry Park in Beijing, China. Established in 2014, the company focuses on providing comprehensive pharmaceutical technology services, particularly in the realm of generic drug development and consistency evaluation. Their service portfolio includes formulation research, CMC (Chemistry, Manufacturing, and Controls) development, analytical testing, and regulatory submission support. The firm is dedicated to assisting pharmaceutical manufacturers in upgrading their product quality to meet stringent national standards. With a focus on small molecule therapeutics, Beijing Deliyingjie facilitates the transition of drug candidates from laboratory research to commercial-scale production through robust technology transfer processes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Deliyingjie Pharmaceutical Technology.